D-cycloserine for numbing and avoidance in chronic PTSD
Phase 2
- Conditions
- Post-traumatic stress disorder.Post-traumatic stress disorder
- Registration Number
- IRCT2013121015741N1
- Lead Sponsor
- Isafahan Univaersity of Medical Sciences, Deputy of Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 76
Inclusion Criteria
Inclusion: male; age over 18 and less than 65 years; being registered were registered with chronic combat-related PTSD in University affiliated psychiatric outpatient clinics in Isfahan;if already on psychopharmacologic treatments were required to be on a stable adequate drug regimen for the past three months.
Exclusion: criteria of another DSM-IV-TR diagnosis; comorbid psychiatric condition including depression or substance abuse; a comorbid serious medical problem.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umbing and avoidance scores. Timepoint: 1st week, 5th, 7th, 11th weeks. Method of measurement: Clinician Administered PTSD Scale, Criterion C.
- Secondary Outcome Measures
Name Time Method Drug side effects. Timepoint: 1st, 5th, 7th,11th weeks. Method of measurement: Drug side effect questionnaire.